Charles Chen

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

Scott M. Wilhelm, Christopher Carter, LiYa Tang et al. · Cancer Research · 2004 · 4K citations · Full text

Mutant Braf, Raf/mek/erk Pathway, Medicine +12

Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5

Li Liu, Yichen Cao, Charles Chen et al. · Cancer Research · 2006 · 1.5K citations · Full text

Chemoprevention Strategy, Immunology, Cell Death +19

Gemini: A Family of Highly Capable Multimodal Models

Gemini Robotics Team, Rohan Anil, Sebastian Borgeaud et al. · arXiv (Cornell University) · 2023 · 784 citations · Full text

Artificial Intelligence, Natural Language Processing, New Family +15

Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

Yong S. Chang, Jalila Adnane, Pamela A. Trail et al. · Cancer Chemotherapy and Pharmacology · 2006 · 462 citations

Oncology, Medicine, Tumor Growth +10

<i>ZmCCT</i> and the genetic basis of day-length adaptation underlying the postdomestication spread of maize

Hsiao-Yi Hung, Laura M. Shannon, Feng Tian et al. · Proceedings of the National Academy of Sciences · 2012 · 337 citations · Full text

Diverse Teosintes, Plant Genetics, Genetics +18